Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
QIMC Identifies Three Fault-Controlled Helium Zones at New Salem-Apple River, Nova Scotia, and Expands Seismic Program to Approximately 50 Line-Kilometres
Flow Metals Identifies Widespread Epithermal Alteration and District-scale Structural Controls at Sixtymile
